Capricor Therapeutics announced its Q3 2026 financial results and progress on its Duchenne muscular dystrophy (DMD) therapy, Deramiocel. The FDA is reviewing the Biologics License Application (BLA) with a PDUFA date set for November 22, 2026, following submission of two-year extension data showing a 76% slower decline in upper limb function. The therapy also received an American Heart Association award for cardiac benefits. Capricor is preparing for potential commercial launch with a strong cash position of $199 million and ongoing manufacturing expansion. The company expects to update its financial outlook after regulatory clarity and continues to resolve a distribution dispute in arbitration.
Capricor Therapeutics reported a strong cash position of $199 million as of its Q3 2026 update. For readers following the health sector, here is Pluang's market snapshot as of Nov 11, 2026 04:02 WIB: out of 150 priced US health stocks, 52 rose and 97 fell. Notable movers include ACADIA Pharmaceuticals Inc. (ACAD) up 11.24% at USD 18.36 with 71% buy activity, Ionis Pharmaceuticals Inc. (IONS) down 9.35% at USD 28.10, and Crispr Therapeutics AG (CRSP) down 8.73% at USD 45.67 with 99% sell activity.
Cannabis Strategic Ventures has finalized its change of control with Scopien Technologies, an AI platform company, which now holds voting control through preferred stock. The company has appointed new leadership, including CEO Zameer Mulla, and plans...
Star Bulk Carriers Corp. has published its 2025 Environmental, Social and Governance (ESG) Report, its eighth annual report detailing the company's sustainability strategy, performance, and future objectives. The report, guided by the ESG Committee, ...
TELA Bio reported $19 million revenue in Q3 2026, down 8% year-over-year but with an 18% increase in international sales. The company reduced its operating loss by 21% sequentially and improved adjusted EBITDA loss by 55%, driven by a strategic cost ...
Auburn National Bancorporation, Inc. announced a quarterly cash dividend of $0.27 per share, payable on December 28, 2026, to shareholders recorded by December 10, 2026. The company is the parent of AuburnBank, an Alabama state-chartered bank with ab...
OpenTable's 2027 Quebec dining trends report shows a 9% increase in restaurant bookings, with 65% of Quebecers planning to dine out as much or more in 2027. Consumers prioritize value, local favorites, and meaningful experiences, often celebrating sm...
